Hyperinsulinism

Metabolic·MeSH: Hyperinsulinism

6 drugs in development·2 companies·0 clinical trials

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
avexitide	Eiger BioPharmaceuticals, Inc. (EIGR)
ersodetug	Rezolute, Inc. (RZLT)

Phase 2(4)

Drug	Company
rz358 sequential group cohort 1	Rezolute, Inc. (RZLT)
rz358 sequential group cohort 2	Rezolute, Inc. (RZLT)
rz358 sequential group cohort 3	Rezolute, Inc. (RZLT)
rz358 sequential group cohort 4	Rezolute, Inc. (RZLT)

Compare drugs

avexitide vs ersodetug avexitide vs rz358 sequential group cohort 1 avexitide vs rz358 sequential group cohort 2

Deep-dive into Hyperinsulinism

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis

Hyperinsulinism — Drugs in Development & Clinical Trials | BioSniper